Skip to main content
. 2020 May 30;14(3):343–348. doi: 10.4103/sja.SJA_34_20

Table 2.

Pre-procedure medications

Variable (n=74) Frequency (%)
Beta-blockers 54 (73)
Angiotensin receptor blockers 10 (13.5)
Calcium channel blockers 12 (16)
Angiotensin-converting enzyme inhibitors 20 (27)
Thiazide diuretics 3 (4)
Loop diuretics 36 (48.6)
Digitalis 2 (2.7)
Antiplatelet 53 (71.6)
Anticoagulants 16 (21.6)
Statins 36 (48.6)

Data are presented as number and percent